Homocysteine levels in epileptic children receiving antiepileptic drugs

Journal of Child Neurology

Volumn 22, Issue 12, 2007, Pages 1389-1392

  Kurul, Semra ^a   Ünalp, Aycan ^a   Yiş, Uluç ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Antiepileptic drugs; Folic acid; Homocysteine

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYANOCOBALAMIN; ENZYME INDUCING AGENT; FOLIC ACID; HOMOCYSTEINE; OXCARBAZEPINE; VALPROIC ACID;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MONOTHERAPY; PRIORITY JOURNAL; REFERENCE VALUE; SIDE EFFECT; TREATMENT DURATION; VITAMIN BLOOD LEVEL;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; EPILEPSY; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; VALPROIC ACID; VITAMIN B 12;

EID: 36749062528     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807307081     Document Type: Article

References (18)

1. Hamed SA, Nabeshima T. The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins. J Pharmacol Sci. 2005;98:340-353.
2. Temple ME, Luzier AB, Kazierad DJ Homocysteine as a risk factor for atherosclerosis. Ann Pharmacother. 2000;34:57-65.
3. Moller J., Nielsen GM, Tvedegaard KC, et al. A meta-analysis of cerebrovascular disease and hyperhomocysteinemia. Scand J Clin Lab Invest. 2000;60:491-500.
4. Van Beynum IM, Smeitink JA, den Heijer M., et al. Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation. 1999;99:2070-2072.
5. Diaz-Arrastia R. Homocysteine and neurologic disease. Arch Neurol. 2000;57:1422-1427.
6. Verrotti A., Pascarella R., Trotta D., et al. Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res. 2000;41:253-257.
7. Huemer M., Ausserer B., Graninger G., et al. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation. Epilepsia. 2005;46:1677-1683.
8. Vilaseca AM, Moyano D., Ferrer I., Artuch R. Total homocysteine in pediatric patients. Clin Chem. 1997;43:690-692.
9. Osganian S., Stampfer MJ, Spiegelman D., et al. Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health. JAMA. 1999;281:1189-1196.
10. Karabiber H., Sönmezgöz E., Özerol E., et al. Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B 12 and folic acid. Brain Dev. 2003;25:113-115.
11. Tamura T., Aiso K., Johnston KE, et al. Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy. Epilepsy Res. 2000;40:7-15.
12. Yoo JH, Hong SB A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants. Metabolism. 1999;48:1047-1051.
13. Schwaninger M., Ringleb P., Winter R., et al. Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia. 1999;40:345-350.
14. Ono H., Sakamoto A., Eguchi T., et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants. Metabolism. 1997;46:959-962.
15. Sinischalchi A., Mancuso F., Gallelli L., et al. Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol Res. 2005;52:367-375.
16. Selhub J., Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med. 1995;332:286-291.
17. Gidal B., Tamura T., Hammer A., Vuong A. Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy. Epilepsy Res. 2005;64:161-166.
18. Selhub J., Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.